Chemours (CC)
NYSE: CC
· Real-Time Price · USD
14.71
-0.27 (-1.80%)
At close: Sep 04, 2025, 10:06 AM
-1.80% (1D)
| Bid | 14.69 |
| Market Cap | 2.2B |
| Revenue (ttm) | 5.88B |
| Net Income (ttm) | -420M |
| EPS (ttm) | -2.74 |
| PE Ratio (ttm) | -5.37 |
| Forward PE | 7.1 |
| Analyst | Buy |
| Ask | 14.73 |
| Volume | 222,696 |
| Avg. Volume (20D) | 4,294,735 |
| Open | 14.97 |
| Previous Close | 14.98 |
| Day's Range | 14.65 - 15.02 |
| 52-Week Range | 9.13 - 22.38 |
| Beta | 1.59 |
Analyst Forecast
According to 0 analyst ratings, the average rating for CC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Chemours is scheduled to release its earnings on
Nov 3, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago
+17.95%
Chemours shares are trading higher after announcin...
Unlock content with
Pro Subscription
1 month ago
+6.17%
Chemours shares are trading higher after the company announced it was part of a $875 million PFAS settlement.
3 weeks ago · seekingalpha.com
Chemours: Solid Q2 And Legal Progress Are Bullish (Rating Upgrade)Chemours is showing financial improvement, especially in Opteon refrigerants, despite industry headwinds and a recent dividend cut. The company's legal overhang is easing after a favorable New Jersey ...
